RE:RE:RE:RE:st peter, you sent me a pmwith all due respect st.peter, I dont think the email below is legit. Given your real name is Keith, but the suspect part is your email is info@vaxil.com. That is very odd.
saintpeter wrote: this is for only so many eyes for a calmer board if you get my drift
-----Original Message-----
From: Keith <info@vaxil-bio.com>
Sent: Thursday, May 28, 2020 6:10 PM
To: David Goren <david.goren@epionehp.com>
Subject: PP
From: Keith
Subject: PP
Message Body:
Hello David
I'm sure that you are aware of the outcome of this has done to the market share price. I would like to know why this wasn't put out in a new release ahead of time there are a lot of loyal investors loosing their shirts because of this blind side especially when a couple of week ago you said no funds needed and I know these things take time to arrange so please give me the courtesy of a reply to this email
thankyou for your time on this matter
Keith
this is his reply
Hi Keith.
I hope you are well.
We issue press releases to inform shareholders and others when we have meaningful results to report - including scientific and financial. We cannot issue press releases that are speculative. In any company, there will always be a variety of discussions and negotiations going on, some of which will conclude in a deal and others won't. The release is issued only if and once the deal is done. These are the rules we and all companies are required to follow.
The press release for the fund raise was issued in keeping with regulatory requirements and guidelines.
In addition, we have always said that we need to raise money to progress our program, including in each and every financial statement release (quarterly and annual). We are obligated to explore all options so that we ensure the best possible outcome for investors both in the short- and long-term. This funding is necessary in that context.
Thanks for taking the time to write and I wish you good health, Keith.
David